Clinical Trials Logo

Clinical Trial Summary

Glucocorticoids therapy exposes the patient to an increased risk for diabetes morbidity. However, there is no proven preventive therapy. GLP-1-RA has shown to improve glucose metabolism in healthy volunteers treated with glucocorticoids. We assume that GLP-1-RA will improve glucose metabolism in patients with high risk for diabetes morbidity, treated with glucocorticoids.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT02016846
Study type Interventional
Source Rabin Medical Center
Contact Amit Tirosh, MD
Phone +972.50.8191078
Email tiroshamit@gmail.com
Status Not yet recruiting
Phase Phase 3
Start date January 2014